GlassScriptPhysician profile
John V Marraccini
NPI 1679651665
$1,182.43
in general payments reported to CMS, 2019-2025
16 companies · $200 in 2025
The $200 reported for 2025 was more than what 86% of Forensic Pathology providers received nationally (typical 2025 total: $92.42).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $161 · 2021: $176 · 2022: $41.77 · 2023: $150 · 2024: $270 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $257.95 | 2019-2025 | Arexvy, Shingrix |
| Lilly USA, LLC | $240.16 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $149.95 | 2020-2025 | |
| Exact Sciences Corporation | $89.36 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $80.12 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $71.32 | 2020-2024 | Gardasil, Gardasil 9, Capvaxive |
| Genentech USA, INC. | $45.13 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.91 | 2020 | |
| Astellas Pharma US INC | $40.92 | 2024 | Veozah |
| Allergan, INC. | $29.04 | 2019-2020 | |
| Edwards Lifesciences Corporation | $28.20 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $24.86 | 2025 | Airsupra |
| Novo Nordisk INC | $24.34 | 2025 | Wegovy |
| Hologic Sales and Service, LLC | $23.51 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $18.30 | 2023 | Prehevbrio |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $15.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Marraccini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.